[DPHARMA] YoY TTM Result on 30-Sep-2017 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- 14.27%
YoY- 19.18%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 573,571 554,341 495,341 429,767 328,308 232,663 171,671 22.24%
PBT 69,625 74,528 54,833 45,270 42,709 46,157 41,729 8.89%
Tax -15,175 -16,919 -9,793 -5,416 -9,379 -8,786 -7,856 11.58%
NP 54,450 57,609 45,040 39,854 33,330 37,371 33,873 8.22%
-
NP to SH 54,450 57,609 45,277 40,548 34,022 34,569 33,873 8.22%
-
Tax Rate 21.80% 22.70% 17.86% 11.96% 21.96% 19.04% 18.83% -
Total Cost 519,121 496,732 450,301 389,913 294,978 195,292 137,798 24.71%
-
Net Worth 584,565 505,919 501,487 474,230 451,913 268,530 187,531 20.84%
Dividend
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Div 37,536 33,094 20,937 7,085 8,084 25,710 24,291 7.51%
Div Payout % 68.94% 57.45% 46.24% 17.47% 23.76% 74.38% 71.71% -
Equity
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Net Worth 584,565 505,919 501,487 474,230 451,913 268,530 187,531 20.84%
NOSH 706,026 680,106 661,881 278,959 278,959 278,959 138,912 31.09%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 9.49% 10.39% 9.09% 9.27% 10.15% 16.06% 19.73% -
ROE 9.31% 11.39% 9.03% 8.55% 7.53% 12.87% 18.06% -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 82.42 82.18 75.07 154.06 117.69 139.50 123.58 -6.52%
EPS 7.82 8.54 6.86 14.54 12.20 20.73 24.38 -17.24%
DPS 5.50 5.00 3.17 2.54 2.90 15.42 17.50 -17.52%
NAPS 0.84 0.75 0.76 1.70 1.62 1.61 1.35 -7.59%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 59.58 57.58 51.46 44.64 34.10 24.17 17.83 22.24%
EPS 5.66 5.98 4.70 4.21 3.53 3.59 3.52 8.22%
DPS 3.90 3.44 2.17 0.74 0.84 2.67 2.52 7.54%
NAPS 0.6072 0.5255 0.5209 0.4926 0.4694 0.2789 0.1948 20.84%
Price Multiplier on Financial Quarter End Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 -
Price 3.16 1.40 1.23 2.20 2.06 2.72 3.17 -
P/RPS 3.83 1.70 1.64 1.43 1.75 1.95 2.57 6.86%
P/EPS 40.39 16.39 17.93 15.14 16.89 13.12 13.00 20.77%
EY 2.48 6.10 5.58 6.61 5.92 7.62 7.69 -17.17%
DY 1.74 3.57 2.58 1.15 1.41 5.67 5.52 -17.48%
P/NAPS 3.76 1.87 1.62 1.29 1.27 1.69 2.35 8.14%
Price Multiplier on Announcement Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 12/11/20 29/11/19 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 -
Price 4.04 1.39 1.07 2.20 2.10 2.70 3.01 -
P/RPS 4.90 1.69 1.43 1.43 1.78 1.94 2.44 12.31%
P/EPS 51.63 16.28 15.59 15.14 17.22 13.03 12.34 26.91%
EY 1.94 6.14 6.41 6.61 5.81 7.68 8.10 -21.17%
DY 1.36 3.60 2.97 1.15 1.38 5.71 5.81 -21.47%
P/NAPS 4.81 1.85 1.41 1.29 1.30 1.68 2.23 13.65%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment